2018 Events
Thursday, February 15, 2018 | 3:00 - 4:30 pm San Diego Convention Center, Room 29AB Program Faculty: Chris Griffiths, Paolo Gisondi, Peter van de Kerkhof
Saturday, March 24 | 9:00 am – 6:00 pm Sunday, March 25 | 9:00 am – 3:00 pm Novotel hotel Program Chair: Murlidhar Rajagopalan Program Faculty: Alan Menter, Lars Iversen, Sushil Tahiliani
Saturday, April 28, 2018 | 8:30 - 10:30 am Grand Fiesta Americana
Program Chairs: Claudia de la Cruz & Ricardo Romiti Program Faculty: Matthias Augustin, André Vicente Esteves de Carvalho, Matías Maskin, Fernando Valenzuela
Wednesday, May 16, 2018 | 1:00 - 4:30 pm Rosen Shingle Creek Resort, Room St. John’s 28 & 29 – Level 2
Program Chairs: Hervé Bachelez & Johann Gudjonsson Program Faculty: Jonathan Barker, Nicole Ward, Kazumitsu Sugiura Poster Presentations: Zeyu Chen, Helen Hermann, Mark Mellett, Sara Brown, Marilyn Wan, Zhu Shen, Shuai Shao
Wednesday, September 12, 2018 | 10:00 am - 1:00 pm Palais des Congrès de Paris, Room 242AB Program Chair: Peter van de Kerkhof Program Faculty: Murlidhar Rajagopalan, Peter van de Kerkhof, & Claus Zachariae
Friday, November 16 | 12:30 - 2:00 pm
Program Chairs: Matías Maskin & Ricardo Romiti Program Faculty: Claudia de la Cruz, Carle Paul, César Gonzalez, & Fernando Valenzuela
congress coverage AAD 2019 Annual Meeting Read the psoriasis highlights from the congress learn more
UPCOMING EVENT Hot topics and challenging cases in psoriasis: A focus on pustular, biosimilars, pediatrics and treating in under-served areas Monday, june 10, 2019 1:30 – 4:30 pm milan, italy Register Now
IPC Psoriasis Review Newsletter IPC's bi-annual review of the latest manuscripts in the field of psoriasis. Read the latest issue
IPC's bi-annual review of the latest manuscripts in the field of psoriasis.
Psoriasis News Lilly to Present 5-Year Sustained Efficacy and Safety Results for Taltz® (ixekizumab) in Patients with Plaque Psoriasis at the World Congress of Dermatology6/11/2019 9:58:00 AM Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments6/5/2019 12:03:00 PMCorticosteroid therapy is regarded as first-line therapy for treating mild psoriasis and recalcitrant lesions. Members of the IPC Topical Therapies Working Group reviewed available international topical corticosteroids guidelines in order to understand current information and to identify areas that would benefit from greater practical guidance for dermatologists. FDA Approves ETICOVO™ (etanercept-ykro), Samsung Bioepis' Second Anti-TNF Medicine in the United States4/29/2019 7:28:00 AM AbbVie Announces Approval of SKYRIZI™ for the Treatment of Psoriasis in US, Canada, Europe and Japan4/28/2019 8:26:00 PM More News